Rayonier Advanced Materials (RYAM) Form 144 Notice for 11,051 Shares

Rhea-AI Filing Summary

Form 144 filing for RYAM reporting proposed sale of 11,051 common shares valued at $79,014.65. The shares are held in accounts at Morgan Stanley Smith Barney LLC and the planned sale is expected on 09/19/2025 on the NYSE. The filer acquired the shares as performance stock units on 03/14/2024 (1,651 shares), 02/28/2023 (2,762 shares) and 03/20/2023 (6,638 shares). Payment for the securities is noted as cash with a payment date of 09/12/2025. No securities of the issuer were reported sold by the filer in the past three months according to this notice.

Insights

Securities Analyst

TL;DR: Insider filing shows planned sale of 11,051 RYAM shares worth ~$79k; disclosure signals routine liquidity, not necessarily material.

The Form 144 documents a proposed sale under Rule 144 of 11,051 common shares held as performance stock units and routed through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $79,014.65 and an expected sale date of 09/19/2025. Given total shares outstanding of 67,000,882 reported on the form, the block represents a de minimis portion of the register. The filing fulfills regulatory notice requirements and records acquisition dates and nature of grant, supporting traceability of vested compensation-related holdings.

Corporate Governance Expert

TL;DR: The filing is a standard Rule 144 disclosure tied to performance unit vesting; it documents compliance with sale notification rules.

The notice identifies the securities as performance stock units acquired on three dates in 2023 and 2024 and indicates cash payment timing. The representation about lack of material nonpublic information is included, as required. There are no reported sales in the prior three months, and the broker and exchange are specified, which are consistent with routine orderly disclosure rather than a change in corporate control or material event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11051	79014.65	67000882	09/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/14/2024	Performance Stock Units	Issuer			1651	09/12/2025	Cash
Common	02/28/2023	Performance Stock Units	Issuer			2762	09/12/2025	Cash
Common	03/20/2023	Performance Stock Units	Issuer			6638	09/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for RYAM report?

The Form 144 reports a proposed sale of 11,051 common shares of RYAM with an aggregate market value of $79,014.65 to be sold on 09/19/2025 on the NYSE.

How were the RYAM shares being sold acquired?

The shares were acquired as performance stock units on 03/14/2024 (1,651), 02/28/2023 (2,762), and 03/20/2023 (6,638).

Through which broker will the RYAM shares be sold?

The sale is scheduled to be executed through Morgan Stanley Smith Barney LLC, address listed in the filing.

Does the filing report any sales in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

What representation does the filer make regarding material nonpublic information?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed, and references Rule 10b5-1 plan conditions if applicable.